Aromatase inhibitors in breast cancer: Current and evolving roles

  • Cleveland Clinic Journal of Medicine
  • July 2002,
  • 69
  • (7)
  • 561-567;

ABSTRACT

The aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well.

Loading
  • Print
  • Download PDF
  • Article Alerts
  • Email Article
  • Citation Tools
  • Share

Jump to section